Oruka Therapeutics (ORKA) Non-Current Assets (2010 - 2026)

Oruka Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $109.2 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 336.42% year-over-year to $109.2 million; the TTM figure through Mar 2026 stood at $433.5 million (up 855.99% YoY), while the FY2025 annual figure was $144.8 million, up 655.93% from the prior year.
• Non-Current Assets was $109.2 million for Q1 2026 at Oruka Therapeutics, down from $144.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $154.1 million in Q3 2025 to a low of $24000.0 in Q2 2024.
• Historically, Non-Current Assets has averaged $28.3 million across 5 years, with a median of $446000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 92.68% in 2024, then soared 105758.33% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $386000.0 in 2022, then sank by 30.31% to $269000.0 in 2023, then jumped by 7018.96% to $19.2 million in 2024, then jumped by 655.93% to $144.8 million in 2025, then declined by 24.54% to $109.2 million in 2026.
• The last three Non-Current Assets figures came in at $109.2 million (Q1 2026), $144.8 million (Q4 2025), and $154.1 million (Q3 2025), per Business Quant data.